The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
about
Carcinoid tumorsMedullary thyroid carcinoma: targeted therapies and future directionsLithium inhibits carcinoid cell growth in vitroAzacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids.Valproic acid induces Notch1 signaling in small cell lung cancer cellsInhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumorsSignaling mechanisms in neuroendocrine tumors as targets for therapy.Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature.Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathwaysProtein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors.Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsSignaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth.Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion.
P2860
Q24614827-BAB4E580-0D67-45F8-A9DF-BD1CDD062478Q33557376-C9E5A49C-93A4-429C-9F81-F82B90AAC7F7Q33942103-74A78083-4A20-4FC5-9044-FB95A0B1D284Q33951168-690B1C2A-FF85-474A-A682-945A51ED875BQ33976203-AE8CB8DD-210E-478A-A4CD-9B82ED217A13Q34048712-D6F74042-6767-436A-9664-60F0633DBC66Q34447484-6F1FCA4E-3065-40AB-A16A-B23DAD507B97Q35866294-F8919C3F-97DC-4B71-80BF-21E8051D5D55Q36334183-9BBC1A1C-2AE1-4DB1-9D33-FC0682B37A6AQ36480150-496D3A09-B0D8-4672-A43D-096FBECE2CBEQ36536629-52DE36B8-CC9F-45FD-9A40-07F4CCB43C3CQ36790872-55D91D36-C9CD-4727-9C69-1BBF015AE57AQ37091159-0747C069-77A3-401E-BE4F-B5A0584CAD35Q37179117-7D534CF9-5CB1-4C5A-A19E-33EE723E1C7BQ37985518-2FF2C278-37C9-413F-AA20-6BC0B2BA262BQ39042894-34829763-FF34-4DFF-B0D1-4D457A96808DQ39747646-2C6DF6B3-8D5A-4705-8059-1135B26CB97BQ40167201-1FDDB0D7-708F-4B31-A72C-226B00D7F676
P2860
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@ast
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@en
type
label
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@ast
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@en
prefLabel
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@ast
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@en
P1433
P1476
The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?
@en
P2093
Herbert Chen
Muthusamy Kunnimalaiyaan
P304
P356
10.1097/00001813-200602000-00004
P577
2006-02-01T00:00:00Z